Seres Therapeutics Inc

NASDAQ:MCRB 4:00:00 PM EDT

0.73

-0.03 (-4.01%)

7:54:04 PM EDT: $0.74 +0.01 (+1.29%)

Market Cap (Intraday)	110.16M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.25 Million
Adjusted EPS	-$0.34

See more estimates

10-Day MA	$0.67
50-Day MA	$0.86
200-Day MA	$1.89

See more pivots

Seres Therapeutics Inc Stock, NASDAQ:MCRB

200 Sidney Street, 4th floor, Cambridge, Massachusetts 02139

United States of America

Phone: +1.617.945.9626

Number of Employees: 233

http://www.serestherapeutics.com

Description

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.